Study of Extracellular Vesicles (EV) in Patients Undergoing CAR-T Cell Therapies

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

August 31, 2026

Conditions
CAR-T Cell TherapyExtracellular Vesicles
Interventions
OTHER

Patients who are candidates for CAR-T cell therapy for hematologic malignancy

This study will include patients who undergo CAR-T cell infusion at participating centers during the 18-month duration of the enrollment period. A total of 100 patients are expected to be enrolled, including 80 patients for the prospective part and 20 for the retrospective part.

Trial Locations (1)

40138

RECRUITING

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna

All Listed Sponsors
lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER